Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Immune pathogenesis of apoptosis of CD34 multipotential hematopoietic cells in acquired aplastic anemia. Antigens are presented to T lymphocytes by antigen-presenting cells (APCs). This triggers T cells to activate and proliferate. T-bet, a transcription factor, binds to the interferon-γ (IFN-γ) promoter region and induces gene expression. SLAM-associated protein (SAP) binds to Fyn and modulates the signaling lymphocyte activation molecule (SLAM) activity on IFN-γ expression, diminishing gene transcription. Patients with aplastic anemia show constitutive T-bet expression and low SAP levels. IFN-γ and tumor necrosis factor-α (TNF-α) upregulate both the T cell's cellular receptors and the Fas receptor. Increased production of interleukin-2 leads to polyclonal expansion of T cells. Activation of the Fas receptor by the Fas ligand leads to apoptosis of target cells. Some effects of IFN-γ are mediated Source: Aplastic Anemia: Acquired and Inherited, Williams Hematology, 9e through interferon regulatory factor 1 (IRF-1), which inhibits the transcription of cellular genes and entry into the cell cycle. IFN-γ is a potent inducer of Kaushansky K, Lichtman MA, Prchal JT,(NOS), Levi MM, OW, Burns Caligiuri M. Williams Hematology, 9e;diffuse 2015 Available at: many cellularCitation: genes, including inducible nitric oxide synthase andPress production of the LJ, toxic gas, nitric oxide (NO), may further the toxic effects. http://mhmedical.com/ Accessed: May 07, 2017 These events ultimately lead to reduced cell cycling and cell death by apoptosis. (Reproduced with permission from Young NS, Calado RT, Scheinberg P: Copyright 2017 McGraw-Hill rights reserved Current concepts in the©pathophysiology andEducation. treatment All of aplastic anemia. Blood 2006 Oct 15;108(8):2509-2519.)